FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Montelukast Sodium Chewable Tablet
Status: Discontinuation
»Therapeutic Categories: Pediatric; Pulmonary/Allergy

Expand all

Mylan Pharmaceuticals Inc. (New 12/12/2017)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Montelukast Sodium Chewable Tablets, 5 mg (NDC 0378-5205-93) 12/12/2017 Discontinuation of the manufacture of the drug product.
Montelukast Sodium Chewable Tablets, 4 mg (NDC 0378-5204-93) 12/12/2017 Discontinuation of the manufacture of the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English